Literature DB >> 18428027

Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein.

Patricia de Winter1, Patricia Leoni, David Abraham.   

Abstract

Connective tissue growth factor (CTGF) is a member of the CCN family of six small secreted, cysteine-rich growth factors. The unique modular structure encompasses distinct functional domains which enable CTGF to interact with growth factors, surface receptors and matrix components. Widely expressed, CTGF has critical roles in embryonic development and the maintenance of normal cell and connective tissue function. It is also important for tissue repair following injury, and has been implicated in common diseases including atherosclerosis, pulmonary and renal fibrotic disorders and cancer. Factors that regulate CTGF transcription in response to exogenous stimuli, as well as downstream signalling pathways, have been described. However, only recently have studies begun to unravel how the functional domains within the CTGF modules orchestrate signals and control key biological processes. This article highlights how the structural and functional domains of CTGF and CTGF cleavage fragments integrate multiple extracellular events into cell signals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428027     DOI: 10.1080/08977190802025602

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  59 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 2.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 3.  EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets.

Authors:  M Kidd; S Schimmack; B Lawrence; D Alaimo; I M Modlin
Journal:  Neuroendocrinology       Date:  2012-06-15       Impact factor: 4.914

4.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

5.  First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering.

Authors:  Kenneth P Holbourn; Marc Malfois; K Ravi Acharya
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

6.  Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.

Authors:  Andreea M Bujor; Sashidar Nakerakanti; Erin Morris; Faye N Hant; Maria Trojanowska
Journal:  Exp Dermatol       Date:  2010-02-25       Impact factor: 3.960

Review 7.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

8.  Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.

Authors:  Jamie L Fox; Michael Dews; Andy J Minn; Andrei Thomas-Tikhonenko
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

9.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

10.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.